160
Views
5
CrossRef citations to date
0
Altmetric
Original Articles

Patients with tuberculous meningitis and hepatitis B co-infection have increased risk for antituberculosis drug-induced liver injury and poor outcomes

ORCID Icon, , , ORCID Icon & ORCID Icon
Pages 793-800 | Received 07 Mar 2020, Accepted 20 Jun 2020, Published online: 03 Jul 2020

References

  • WHO (2019) Global tuberculosis report 2019. https://www.who.int/tb/publications/global_report/en/. Accessed 10 Oct 2019
  • Cantier M, Morisot A, Emmanuel G, et al.; ENCEPHALITICA Study Group. Functional outcomes in adults with tuberculous meningitis admitted to the ICU: a multicenter cohort study. Crit Care. 2018;22(1):210.
  • Alyssa M, Kiran T, Christopher V. Tuberculous Meningitis in children and adults: new insights for an ancient foe. Curr Neurol Neurosci Rep. 2017;17(11):85.
  • Pormohammad A, Nasiri MJ, Riahi SM, et al. Human immunodeficiency virus in patients with tuberculous meningitis: systematic review and meta-analysis. Trop Med Int Health. 2018;23(6):589–595.
  • Garg RK, Rizvi I, Malhotra HS, et al. Management of complex tuberculosis cases: a focus on drug-resistant tuberculous meningitis. Expert Rev Anti Infect Ther. 2018;16(11):813–831.
  • Davis A, Meintjes G, Wilkinson RJ. Treatment of tuberculous meningitis and its complications in adults. Curr Treat Opt Neurol. 2018;20(3):5.
  • TB Society of Chinese Medical Association. Guidelines for the diagnosis and treatment of anti-tuberculosis drug-induced liver injury (2019 edition). Chin J Tuberc Respir Dis. 2019;42(5):343–356.
  • Chang T-E, Huang Y-S, Chang C-H, et al. The susceptibility of anti-tuberculosis drug-induced liver injury and chronic hepatitis C infection: a systematic review and meta-analysis. J Chin Med Assoc. 2018;81(2):111–118.
  • Wang NT, Huang YS, Lin MH, et al. Chronic hepatitis B infection and risk of antituberculosis drug-induced liver injury: systematic review and meta-analysis. J Chin Med Assoc. 2016;79(7):368–374.
  • Marais S, Thwaites G, Schoeman JF, et al. Tuberculous meningitis: a uniform case definition for use in clinical research. Lancet Infect Dis. 2010;10(11):803–812.
  • Infectious Diseases Society of Chinese Medical Association, Society of Hepatology of Chinese Medical Association. Guidelines for the prevention and treatment of chronic hepatitis B (2019 edition). Chin J Infect Dis. 2019;37(12):711–736.
  • Lomtadze N, Kupreishvili L, Salakaia A, et al. Hepatitis C virus co-infection increases the risk of anti-tuberculosis drug-induced hepatotoxicity among patients with pulmonary tuberculosis. PLoS One. 2013;8(12):e83892.
  • Chen LB, Bao DJ, Gu L, et al. Co-infection with hepatitis B virus among tuberculosis patients is associated with poor outcomes during anti-tuberculosis treatment. BMC Infect Dis. 2018;18(1):295.
  • Rhea M, Trainee GP, Chinthapalli K, Consultant neurologist. Glasgow coma scale explained. BMJ. 2019;365:l1296.
  • Thao LTP, Heemskerk AD, Geskus RB, et al. Prognostic models for 9-month mortality in tuberculous meningitis. Clin Infect Dis. 2018;66(4):523–532.
  • Solomons RS, Wessels M, Visser DH, et al. Uniform research case definition criteria differentiate tuberculous and bacterial meningitis in children. Clin Infect Dis. 2014;59(11):1574–1578.
  • Li KY, Tang H, Yang Y, et al. Clinical features, long-term clinical outcomes, and prognostic factors of tuberculous meningitis in West China: a multivariate analysis of 154 adults. Expert Rev Anti Infect Ther. 2017;15(6):629–635.
  • Mihaja R, Rivo AR, Tiana R, et al. Clinical features and outcome in adult cases of tuberculous meningitis in tertiary care hospital in Antananarivo, Madagascar. BioMed Res Int. 2017;2017:9316589.
  • Croda MG, Vidal JE, Hernandez AV, et al. Tuberculous meningitis in HIV-infected patients in Brazil: clinical and laboratory characteristics and factors associated with mortality. Int J Infect Dis. 2010;14(7):e586–e591.
  • Wong WM, Wu PC, Yuen MF, et al. Antituberculosis drug-related liver dysfunction in chronic hepatitis B infection. Hepatology. 2000;31(1):201–206.
  • Kim WS, Lee SS, Lee CM, et al. Hepatitis C and not hepatitis B virus is a risk factor for anti-tuberculosis drug induced liver injury. BMC Infect Dis. 2016;16(1):50.
  • Hadjihambi A, Arias N, Sheikh MF, et al. Hepatic encephalopathy: a critical current review. Hepatol Int. 2018;12(Suppl 1):135–147.
  • Zhang J, Hu X, Hu X, et al. Clinical features, outcomes and molecular profiles of drug resistance in tuberculous meningitis in non-HIV patients. Sci Rep. 2016;6:19072.
  • Kwak MS, Kim YJ. Occult hepatitis B virus infection. World J Hepatol. 2014;6(12):860–869.
  • Trigo C, Brasil P, Costa MJM, et al. Occult hepatitis B virus infection: clinical implications in tuberculosis treatment. J Viral Hepatol. 2016;23(12):1027–1035.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.